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Abstract
A panel data approach has been used to find the effect of life expectancy on GDP
per capita for 182 countries over 1960-2015. Panel data models are considered and
compared their estimates. Accounting for country fixed effects and dynamics in GDP
per capita, our models document a significantly positive and robust effect of life
expectancy on GDP per capita. The dynamic fixed effects model provides that GDP
per capita increases by 3.5% with a 1% rise in life expectancy: On average around a
20-year rises in life expectancy provides about ✩10,913 more mean GDP per capita
which is large in magnitude. Results remain very similar when using instrumental
variable model. Our investigation suggests that an improvement in life expectancy
increases GDP per capita by reducing fertility and increasing saving.
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1 Introduction
Global health is in two regimes: unhealthy nations with high mortality rates and
healthy nations with few child deaths. Healthier countries are more productive
and thus contribute more in GDP per capita.1 Economic growth in healthier
countries are enough to provide public health care services because health as a
byproduct automatically appear from economic growth.2 Unfortunately, it is
not true for unhealthier nations because their economic growth is a far away
from enough to maintain health care for all citizens (Sachs, 2002). In addition,
health with communicable and preventive diseases in these countries reduce
economic growth and consequently deteriorate health conditions. Health in
these countries can be improved from their own economic growth and a large
philanthropic resources from developed countries (Ashraf et al., 2008). As
described the whole health coverage may not be possible, a combination of both
can be effective to ameliorate health in poor nations. To reduce global health
inequality, an integrated efforts of global community from humanitarian aspects
has commenced in 2000 with a set of goals called the Millennium Development
Goals (MDGs): It achieved considerable success in reducing mortality even
if the target level of two-thirds reduction of child deaths has not reached by
2015 and thus increases life expectancy at birth.3 Following the success from
1We use health to refer to life expectancy at birth or general health outcome or other
health outcomes such as mortality rates and survival rate throughout the paper.
2We also use GDP and income interchangeably to refer to GDP per capita in this paper.
3MDGs are 8 goals: to alleviate extreme poverty and hunger; to achieve universal primary
education; to promote gender equality and empower women; to reduce child mortality;
to improve maternal health; to prevent HIV/AIDS, malaria and other preventive and
communicable diseases; to make sure environmental sustainability and to develop a global
partnership for development.
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MDGs, the sustainable development goals (SDGs) set target of reducing child
deaths under five to 25 per 1,000 by 2035.4 These global attempts promote
global health and economic growth and development. For example, WHO’s
commission reports, chaired by Jeffrey Sachs, on Macroeconomics and Health
(2002):
“For individuals and families, health brings the capacity for personal de-
velopment and economic security in the future. Health is the basis for job
productivity, the capacity to learn in school, and the capability to grow in-
tellectually, physically, and emotionally. As with the economic well-being of
individual households, good population health is a critical input into poverty
reduction, economic growth, and long-term economic development at the scale
of whole societies”.
“Health is a resource that enables every person to realize his or her potential
and to contribute to the overall development of society”(WHO and Others,
2017).
Theoretical and empirical analyzes in growth and other economic fields
provide evidence that health is a matter for economic growth. Health can
affect economic growth through mechanisms: First, it affects per capita labor
through fertility. Second, it scales saving up and hence capital formation. The
existing literature has acknowledged the importance of channels via which
health affects the GDP per capita. For instance, Aghion et al. (2010) and Barro
(1996) underscore the significance of investigation of the channels through
which health acts on growth: An improved life expectancy reduces mortality
4Mortality reducing to 25 per 1,000 is one of 17 goals in SDGs.
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and so does fertility which in turn increases the economic growth. A higher life
expectancy can save more and thus economic growth goes up (Zhang and Zhang,
2005). People with a longer life expectancy can reduce fertility which is based
on the condition that they live in a low infant mortality environment (Aghion
et al., 2010). So, both population and fertility go down through demographic
transition with varying lags. This can lead to having more capital per labor
to work with and hence productivity and growth rises. Thus, mechanisms are
important to find how health works on economic growth.
There are a few papers that previously studied the direct link between
general health outcome, measured by life expectancy at birth and GDP per
capita on a big panel dataset over a long time period. To our knowledge, the
first empirical research in this literature started from Barro (1996). He finds a
significantly positive relationship between life expectancy and economic growth
from 1960 to 1990 while Acemoglu and Johnson (2007) find no impacts of life
expectancy on GDP per capita over 1940-1980.5 Thus, there is a mixed in
empirical evidence. However, these papers do not consider time regimes from
2000 to 2015 in which Millennium Development Goals (MDGs) happened when
health has substantially improved by reducing child mortality rates globally.
Furthermore, time regimes 1980 and onwards include global public health goods
such as AIDS/HIV and AMR which did not occur before 1980. The global
mortality instruments constructed byAcemoglu and Johnson (2007) may not
reflect mortality caused by HIV/AIDS as their instruments are based on diseases
occurred in 1940. They also suggest that their results may not apply for present
5Their main time regimes are 1940-1980, however they extended to 2000 to check robust-
ness.
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time because of these global public health goods which were not occurred at
the time regimes considered in their research (Acemoglu and Johnson, 2007,
p. 4). In consequence, these time regimes are important for establishing the
link between income and health. Hence, we enlarge the dimensions of our
panel data unlikely to Acemoglu and Johnson (2007) or Barro (1996): Both
cross-section dimension, N and time series dimension, T increases; N goes to
182 countries and T to 56 years. This allows us find consistent estimates across
cross-section units given stationary process of panel units.
A number of papers related to ours-using different health indicators rather
than life expectancy-investigates the connection between income and health.
For example, Ehrlich and Lui (1991) and Bhargava et al. (2001) discover
a positive impacts of improved health on income by measuring health as
probabilities of survival from ages 0 to 25 and 50 to 75, adult survival rates
over 1960-2010 respectively while Aghion et al. (2010) and Meltzer (1992) find
that there is negative impact of mortality rates on income.
Our interest in this paper is to find a relationship between health and GDP
per capita using panel data estimators. To attain this relation, this paper
follows several strategies: First, we use a dynamic panel model which captures
country fixed effects and persistence in GDP per capita (or dynamics of GDP
per capita). The inclusion of persistence in our model gives us different results
relative to a static panel model. Second, since health is an endogenous variable,
without addressing this issue our estimates may be biased and inconsistent. To
overcome this problem, we follow an instrumental variable (IV) method. Using
lags as internal instruments, we employ the generalized method of moments
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(GMM) estimator. Third, using both estimators, we undertake several strategies
to check robustness of our results such as alternative health measures, time
regimes and outliers. Finally, our paper examines channels through which
health acts on income per capita.
In the literature, there are theoretical analyzes concerning the dynamic
relationship between income and health. For example, Malthus postulates a
negative dynamic relationship between mortality and economic growth (Preston,
1975). Also, studies from Acemoglu et al. (2019), Cuestas and Garratt (2011),
and Chang et al. (2006) demonstrate that there is a high persistence in GDP.
Thus, our conceptual framework of dynamic panel model follows from this.
Controlling the dynamics of GDP, we can account for factors affected past
also affect on current GDP. We can estimate parameters consistently using
the overall amounts of persistence in GDP by employing the dynamic fixed
effects (DFE) and GMM models which allow us to find the long-run effects
of health. As a result, our conceptual framework and data differ from others:
This analysis provides different results from others.
Our contributions in this paper are: First, we find a significantly positive
and robust effect of life expectancy at birth on GDP per capita. Second, we
use an updated yearly dataset from 1960 to 2015 for 182 countries which
covers the entire world. Third, our analysis discovers channels via which life
expectancy affects on GDP per capita. Our preferred estimates from the
dynamic within estimator-baseline model-indicates that GDP per capita rises
by around 3.5% due to a 1% rise in life expectancy at birth in the long-run
: On average, if life expectancy rises by 20 years (for example, from 1950 to
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1970) then mean GDP per capita rises around ✩10,913 more which is a very
large magnitude.6 We obtain a very similar estimate from employing GMM
estimator using internal instruments. Our analysis shows that health raises
income by decreasing fertility and increasing saving.
The paper is organized as follows: Section 2 denotes the data sources and
description. Section 3 explains the econometric models and empirical results.
Section 4 provides the mechanisms and test of mechanisms and concluding
remarks are given in section 5.
2 Data Sources and Description
In our analysis, GDP per capita (constant 2010 U.S. dollars) is our outcome
and life expectancy at birth are independent variables: Data for both variables
are used from the World Bank’s World Development Indicators (World Bank,
2018). Other health indicators we use from this data source include under-
five child mortality (per 1,000 live births), maternal mortality (per 1,000 live
births), male adult mortality (per 1,000 male adult), male survivals to age 65
(percentage of cohort), saving (percentage of GDP) and total fertility rate (the
number of children born per woman). Table 1 presents summary statistics of
outcome and regressors in our model.
6Dynamic within or dynamic fixed effects or within estimators are interchangeably used
in this paper.
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Table 1: Descriptive Statistics
Obs Mean S.D.
GDP per capita 8,097 ✩9,743.86 ✩14,985.53
Life expectancy at birth 10,088 63.18 11.43
Child mortality under five per 1,000 births 8,960 80.65 78.99
Maternal mortality per 1,000 births 4,654 273.61 364.85
Male adult mortality per 1,000 10,013 274.17 115.37
Male survival rate to age 65 10,024 58.45 16.08
Saving 8,097 ✩59,246,602,290.23 ✩256,132,804,227.09
Fertility 10,092 4.158 2.042
Note: The detailed description of variables in the text and sources from where they are used.
3 Panel Data Estimators
Our paper uses two panel estimators to model the relationship between health
and income: Dynamic fixed effects (dynamic within), and Arellano-Bond GMM
(dynamic IV ) estimators.
3.1 Dynamic Fixed Effects Model (Baseline)
Using dynamic panel models, this paper constructs a relationship between
GDP per capita and health. Our dynamic within model is:
yit = βhit +
q∑
l=1
δlyi(t−l) + αi + γt + uit (1)
where, i = 1, 2, . . . , 182, indicates country over the years t = 1960, 1961, . . . , 2015
and l = 1, 2, . . . , q are lags. In this model y, h, yt−l and u represent log of
GDP per capita, log of health, lagged dependent variables and the error term
respectively. Here, health indicates life expectancy at birth and alternative
measures of health (Mortality rates and male survivals). Our interest lies in
estimating β: It is expected to have a positive value indicating a higher GDP is
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correlated with an improvement in life expectancy. δl captures the persistence
in the outcome variable which may be due to the effects of policies that have
previously been taken in each country. αi and γt capture the country and
year fixed effects in our model respectively. The u contains all other factors
excluded from the model.
Our dynamic panel within estimator is consistent provided GDP per capita
is stationary and health is exogenous. The identification of β in model (1)
depends on zero conditional mean of error uit:
Assumption 1: E(uit | hit, yi(t−1), . . . , yi(t−q), αi, γt) = 0, for all hit, yi(t−1),
. . . , yi(t−q), αi and γt.
This is a fundamental assumption conveying conditional mean of uit given
the values of health, past GDP, country and year fixed effects. The implication
of this assumption is that error terms are conditionally uncorrelated: health,
lagged GDP, country and year fixed effects are exogenous.
To find the long-run effects of health on income, we derive the following
formula accounting for the persistence in income. If outcome and explanatory
variables are persistent, then in the steady-state, yit = yss, hit = hss. For
simplicity, ignoring the country and year fixed effects as well as the error term
in model 1, we can attain, yit = yit−l = yss in steady-state. Using these in
model 1, we obtain
yss = βhss +
q∑
l=1
δlyss
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so, yss =
βhss
1−
q∑
l=1
δl
where, yss is a steady-state level of income in the long-run. The long-run
cumulative effects of health is
β
1−
q∑
l=1
δl
, where l are lags, 1 ≤ l ≤ q,
q∑
l=1
δl
represents the sum of autoregressive coefficients indicating the overall amounts
of persistence in income and
q∑
l=1
δl converges to m ∈ (0, 1). Because the long-run
effects of health are obtained after estimation, we use the estimated coefficients
of β and δ. Therefore, the long-run formula becomes
βˆ
1−
q∑
l=1
δˆl
, where
q∑
l=1
δˆl
converges to m ∈ (0, 1) which implies income is stationary.
We can consistently estimate the dynamic effects of health controlling for
the various lagged dependent variables. Table 2 presents the impacts of life
expectancy on income. We control for one lag of outcome variable in column 1,
Panel A. The estimated and long-run effects of life expectancy are positive
and statistically significant: The estimated coefficient for life expectancy is
0.202 (s.e.= 0.091) while in the long-run it is 1.934 (s.e.= 0.677); a 1% rise
in life expectancy contributes around 2% rise in GDP in the long-run. The
persistence in income is 0.896 (s.e.= 0.073) which is less than 1: It implies
income satisfies stationary process. Our estimate of β is consistent provided
model 1 satisfies assumption 1 and GDP is stationary.78
7To find the stationary of GDP per capita, we conduct Fisher-type panel unit root test
for our unbalanced panel data. The p-value of this test rejects the presence of unit root in
GDP per capita. In Fisher-type unit root test, H0: All panels contain unit root; H1: At
least one panel is stationary.
8The maximum lags we considered in our analysis is 5. To select preferred lags, we
set the null hypothesis H0 : γil = 0 on the following augmented Dickey-Fuller regression,
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When we add one more lag in column 2, the estimated effect of life ex-
pectancy is around 0.221% (s.e.= 0.081%) while the estimate for cumulative
long-run effects is around 3.162% (s.e.= 0.903%). Both estimates are higher
than those of column 1. The persistence in GDP is 0.930 (s.e.= 0.041) which
shows that GDP is stationary. With three lags of the outcome variable, our
estimates in column 3 indicate that the amount of long-run effect of health is
3.511% with a standard error of 0.917%. This is our preferred specification.
The sum of autoregressive coefficients is less than one indicating stationarity
of GDP. Columns 4 and 5 with 4 and 5 lags of GDP respectively demonstrate
very similar effects with the estimates of column 3.
Table 2: The effect of life expectancy on GDP per capita
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10)
Dynamic within estimates GMM estimates
Health effect 0.202∗∗ 0.221∗∗∗ 0.095∗∗∗ 0.091∗∗∗ 0.095∗∗∗ 0.464∗∗ 0.471∗∗ 0.146∗∗∗ 0.138∗∗∗ 0.139∗∗∗
(0.091) (0.081) (0.016) (0.015) (0.015) (0.247) (0.200) (0.024) (0.024) (0.025)
GDP per capita 0.896∗∗∗ 0.572∗∗∗ 1.070∗∗∗ 1.163∗∗∗ 1.142∗∗∗ 0.802∗∗∗ 0.492∗∗∗ 1.034∗∗∗ 1.126∗∗∗ 1.111∗∗∗
first lag (0.076) (0.115) (0.052) (0.067) (0.066) (0.133) (0.118) (0.048) (0.072) (0.070)
GDP per capita 0.358∗∗∗ -0.030 -0.136∗ -0.080 0.347∗∗∗ -0.021 -0.117 -0.073
second lag (0.076) (0.023) (0.076) (0.073) (0.031) (0.022) (0.074) (0.072)
GDP per capita -0.067∗∗ -0.022∗∗ -0.064∗∗ -0.050∗∗ -0.018∗∗∗ -0.055∗∗
third lag (0.030) (0.006) (0.028) (0.026) (0.007) (0.025)
GDP per capita -0.036∗∗ -0.021∗∗ -0.050∗∗ -0.018∗∗∗ -0.055∗∗
fourth lag (0.012) (0.010) (0.015) (0.010)
GDP per capita -0.012 -0.006
fifth lag (0.010) (0.008)
Long run 1.934∗∗∗ 3.162∗∗∗ 3.511∗∗∗ 3.000∗∗∗ 2.739∗∗∗ 2.348∗∗∗ 2.936∗∗∗ 3.954∗∗∗ 3.673∗∗∗ 3.349∗∗∗
effect of health (0.677) (0.903) (0.917) (0.704) (0.658) (0.466) (0.548) (0.679) (0.582) (0.549)
Persistence in 0.896∗∗∗ 0.930∗∗∗ 0.973∗∗∗ 0.970∗∗∗ 0.966∗∗∗ 0.802∗∗∗ 0.840∗∗∗ 0.963∗∗∗ 0.962∗∗∗ 0.959∗∗∗
GDP per capita (0.076) (0.041) (0.005) (0.005) (0.006) (0.133) (0.090) (0.007) (0.007) (0.008)
Panel unit root test
of GDP (p-value) [0.000] [0.000] [0.000] [0.000] [0.000]
AR2 test (p-value) [0.652] [0.000] [0.164] [0.252] [0.116]
Observations 7,683 7,507 7,330 7,155 6,979 7,484 7,308 7,133 6,958 6,783
No. of country 182 182 182 182 182 179 179 179 179 179
Note: Dependent variable is log of GDP per capita while independent variable is log of total life expectancy. Columns 1-5 report dynamic
fixed effects estimates while GMM estimates are denoted in columns 6-10 respectively. Robust standard errors for heteroskedasticity
at the country level and serial correlation are reported in parentheses. All specifications include country and year fixed effects.
∗p <0.10, ∗∗p <0.05, ∗∗∗p <0.01.
In all specifications, columns 1-5, GDP is persistent and each estimate
∆yit = θiyit−1 +
∑q
l γil∆yit−l + ǫit (See Baltigi, 2005 p.254; Wooldridge 2002, ch.18).
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is less than 1 indicating that estimates follow limiting distribution. We can
consistently estimate β if GDP is stationary and health is uncorrelated with
the factors in the error term. In dynamic within transformation, we removes
time-invariant unobserved heterogeneity across countries by the time demeaning
of original equation 1. The correlation of time-demeaned error terms decreases
and eventually vanishes as T gets very large. Thus, we can achieve consistent
estimates in dynamic within estimator as T tends to infinity.
Once we use the lagged values of the outcome variable as explanatory
variables, the model suffers from Nickell’s bias which varies with the order of
1/T where T is time period. This bias disappears if T tends to infinity.9 In our
case, each panel contains 56 time period; since our observations are very large,
on average each panel has 42 observations, bias may be less. However, the error
term contains time-varying factors which may affect simultaneously health and
GDP per capita, they may lead our estimates biased and inconsistent. Thus,
health is an endogenous variable. On the other hand, lagged GDP is also
endogenous variable due to its correlation with the error term.
3.2 GMM Estimator
To address endogeneity of lagged outcome variables and health, we employ the
first-differenced generalized method of moments (GMM) developed by Arellano
and Bond (1991) in model 1 which also removes time-invariant factors.10 Since
9Monte Carlo simulation studies explore that this bias declines as time period exceeds 20
(Papaioannou and Siourounis, 2008). Judson and Owen (1999) point out that bias is about
from 1% to 2% of the true parameter when T is 30 and it is around 2% and 3% when T is 20.
10We use the dynamic IV estiamtor or Arellano-Bond GMM estimator or GMM estimator
or differenced GMM interchangeably throughout the paper to refer to the same estiamtor.
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yit−1 is correlated with the first-differenced error term, it cannot be considered
as an instrument for the first differenced lagged outcome variables. However,
yit−2, yit−3,.., are uncorrelated with the error terms which are instruments
for the first-differenced of lagged outcomes. On the other hand, health may
be contemporaneously endogenous. So, hit−1 is no longer an instrument and
hit−2, hit−3,.., are instruments for the first-differenced of health. These internal
instruments must satisfy the following orthogonal moments’ condition in model 1
to identify β:
E(∆uit(his, yis)
′
) = 0, ∀s ≤ t− 2
.
Columns 6-10, Table 2 reports the estimates from Arellano-Bond GMM
estimation. The estimated effects of life expectancy are similar to dynamic
within estimates (columns 1-5). The long-run effects are also comparable
with within estimates. The preferred implied effects of life expectancy from
GMM estimation is 3.954 (s.e=0.679) compared to 3.511 (s.e=0.917) in within
estimate. The overall amounts of persistence in GDP are similar. Our GMM
estimates are very similar to our preferred within estimates. To obtain consistent
estimates, we need to test the assumption of no serial correlation in model 1:
This assumption can be tested by the AR2 test. The p-value of this test is
provided at the bottom which indicates that no autocorrelation assumption
can be rejected for lags 2 (column 2) while we cannot reject for columns 1, 3, 4
and 5. So, our GMM estimates are consistent for lag 3.
Overall, our baseline results of dynamic within estimates of Table 2 show
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a positive and significant relationship between income and health. In all
specifications, columns 1 through 5, persistence in GDP is less than one which
indicates that GDP is stationary. On the other hand, GMM estimates give us
consistent estimates accounting for internal instruments for the lagged outcome
and health.
The difference GMM produces too many instruments, the instrument count
quadratic in T . This generates problem for finite samples and weaken the
Hansen test. For this reason, we cannot report the number of instruments
and Hansen p-value in Table 2 and onward. However, this does not affect our
consistency of estimates. In this context, we need to reduce instruments and
check the robustness of the results (Roodman, 2009). We reduces instruments
substantially and find similar findings to our preferred estimates in robustness
of subsection 3.3 (see Table A.1, Appendix A). Furthermore, in the same
subsection, we account for various strategies to find the robustness of our
results of Table 2 where both dynamic fixed effects and GMM estimators are
considered.
3.3 Robustness
Model 1 captures the time-invariant factors by the country fixed effects while
ignoring the time-varying factors which may be correlated with income and
health simultaneously. We check robustness of our baseline estimates consider-
ing several strategies. We modify the model incorporating alternative health
outcomes which are considered as determinants of income such as under-five
child, adult male and maternal mortality rates on income. Table 3 reports
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the effects of these measures. The estimates from all mortality rates are in-
versely related to income: An improvement in mortality leads to an increase
in income. For example, under-five mortality is highly correlated with life
expectancy; an improved under-five mortality increases some of life expectancy
through increasing saving or reducing fertility and surviving children go to
labor after long time and thus increase in income is much lower than preferred
estimates: A 1% reduction in under-five mortality contributes in income by
0.408% (column 1, Table 3) compared to 3.511% (column 3, Table 2) in the
long-run. However, maternal and adult mortality decline add more GDP per
capita as they may enter labor market. For example, a 0.704% rises in income
due to a 1% decreases in male adult mortality; however this is also less than
our preferred estimates 3.511% (Column 3, Table 2) because adult mortality
reduction increases some of life expectancy. The GMM estimates show that
estimates are consistent with the estimates of baseline results.
Also, our model includes other health indicators such as male survival rate
to age 65 which is a determinant of measuring GDP per capita (Well, 2007).
Column 4 of Table 3 reports the effect of this factor on GDP per capita. Our
results from this measure suggests that our baseline preferred findings remain
similar.
Additionally, considering different subsamples based on different time
regimes, we check robustness which is reported in Table 4. Column 1 of
the table presents preferred estimates reproduced from baseline model taking
into account all years to compare estimates. Columns 2-3 indicate the results
from subsamples relying on year-intervals such as 1980-2015 and 1990-2015
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respectively. The findings are close to preferred estimates. Panel B reports
estimates from Arellano and Bond estimator and specifications in columns 2-3
produce similar to our preferred estimates (Column 1, Panel B).
Table 3: The effects of alternative health outcomes on GDP per capita
Child mort. Adult mort. Mater. Survival
under five male mort. male
Health indicators (1) (2) (3) (4)
Panel A: Dynamic within estimates
Health effects -0.017∗∗∗ -0.021∗∗∗ -0.062∗∗∗ 0.045∗∗∗
(0.003) (0.005) (0.011) (0.008)
GDP per capita 1.154∗∗∗ 1.073∗∗∗ 1.087∗∗∗ 1.035∗∗∗
first lag (0.062) (0.053) (0.087) (0.052)
GDP per capita -0.085 -0.031 -0.036 -0.030∗∗∗
second lag (0.069) (0.024) (0.084) (0.023)
GDP per capita -0.111∗∗∗ -0.071∗∗ -0.142∗∗∗ -0.067∗∗∗
third lag (0.023) (0.031) (0.021) (0.030)
Long run -0.408∗∗∗ -0.704∗∗∗ -0.684∗∗∗ 1.750∗∗∗
effect of health (0.049) (0.167) (0.051) (0.470)
Persistence 0.958∗∗∗ 0.971∗∗∗ 0.909∗∗∗ 0.974∗∗∗
in GDP per capita (0.005) (0.014) (0.005) (0.005)
Observations 7,160 7,279 4,340 7,311
No. of country 183 181 176 176
Panel B: GMM estimates
Health effects -0.023∗∗∗ -0.032∗∗∗ -0.094∗∗∗ 0.064∗∗∗
(0.004) (0.010) (0.019) (0.012)
GDP per capita 1.127∗∗∗ 1.036∗∗∗ 1.023∗∗∗ 1.041∗∗∗
first lag (0.070) (0.050) (0.101) (0.048)
GDP per capita -0.081 -0.023 -0.028 -0.022
second lag (0.068) (0.022) (0.080) (0.022)
GDP per capita -0.102∗∗∗ -0.053∗∗ -0.116∗∗∗ -0.049∗∗
third lag (0.022) (0.027) (0.019) (0.030)
Long run -0.418∗∗∗ -0.800∗∗∗ -0.772∗∗∗ 2.196∗∗∗
effect of health (0.042) (0.149) (0.051) (0.526)
Persistence 0.944∗∗∗ 0.960∗∗∗ 0.878∗∗∗ 0.971∗∗∗
in GDP per capita (0.009) (0.008) (0.024) (0.008)
AR2 test (p-value) [0.017] [0.147] [0.109] [ 0.156]
Observations 6,977 7,094 4,164 7,135
No. of country 183 178 176 176
Note: The dependent variable is log of GDP per capita and independent variables are alternative
health outcomes rather than life expectancy. Columns 1-3 denote under five child, male adult,
and maternal mortality rates respectively while male survival to age 65 is indicated in column 4.
All variables are in log form. We use our preferred lags in this Table: Three lags are used as
a preferred lags in our analysis. Robust standard errors for heteroskedasticity at the country
level and serial correlation are reported in parentheses. All specifications include country and
year fixed effects.
∗p <0.10, ∗∗p <0.05, ∗∗∗p <0.01.
Furthermore, we check robustness of our results in model 1 by accounting for
subsamples by regions (Table 5). The regions we consider are: Asia (South East
15
Asia, Asia Pacific and western Asia), Africa (Sub-Sahara and Arab), America
(North America, Latin and Caribbean) and Europe (Europe and Central Asia).
The estimates are reported in columns 2 through 5 of Table 5 respectively. Our
findings are similar to preferred estimates even though estimates for all regions
are larger except Africa region.
Table 4: The effect of life expectancy on GDP per capita with different time regimes
Year-intervals 60-15 80-15 90-15
(1) (2) (3)
Panel A: Dynamic within estimates
Health effects 0.095∗∗∗ 0.182∗∗∗ 0.208∗∗∗
(0.016) (0.027) (0.032)
GDP per capita 1.070∗∗∗ 1.136∗∗∗ 1.132∗∗∗
first lag (0.052) (0.080) (0.087)
GDP per capita -0.030 -0.054 -0.088
second lag (0.023) (0.083) (0.100)
GDP per capita -0.067∗∗ -0.130∗∗∗ -0.113∗∗∗
third lag (0.030) (0.021) (0.033)
Long-run effect 3.511∗∗∗ 3.731∗∗∗ 2.987∗∗∗
of health (0.917) (0.398) (0.295)
Persistence in 0.973∗∗∗ 0.951∗∗∗ 0.930∗∗∗
GDP per capita (0.005) (0.007) (0.009)
Observations 7,330 5,322 3,946
No. of country 182 182 182
Panel B: GMM estimates
Health effects 0.146∗∗∗ 0.308∗∗∗ 0.389∗∗∗
(0.024) (0.076) (0.103)
GDP per capita 1.034∗∗∗ 1.059∗∗∗ 1.024∗∗∗
first lag (0.048) (0.093) (0.120)
GDP per capita -0.021 -0.040 -0.068
second lag (0.022) (0.079) (0.099)
GDP per capita -0.050∗∗ -0.093∗∗∗ -0.062∗∗∗
third lag (0.026) (0.021) (0.029)
Long-run effect 3.955∗∗∗ 4.172∗∗∗ 3.654∗∗∗
of health (0.679) (0.423) (0.406)
Persistence in 0.963∗∗∗ 0.926∗∗∗ 0.894∗∗∗
GDP per capita (0.007) (0.018) (0.027)
AR2 test (P-value) [0.164] [0.204] [0.930]
Observations 7,133 5,128 3,759
No. of country 179 179 179
Note: Dependent variable is log of GDP per capita while indepen-
dent variable is log of total life expectancy. Columns 1 presents esti-
mates from 1960 to 2015 reproduced from Table 2 to make comparison.
Columns 2-3 present estimates from 1980-2015, and 1990-2015 respec-
tively. Standard errors robust to heteroskedasticity and autocorrelation
at the country level are reported in parentheses. All models include
country and year fixed effects.
∗p <0.10, ∗∗p <0.05, ∗∗∗p <0.01.
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Table 5: The effects of life expectancy on GDP per capita with different regions
Whole World Asia Africa America Europe
(1) (2) (3) (4) (5)
Panel A: Dynamic within estimates
Health effects 0.095∗∗∗ 0.133∗∗ 0.079∗∗∗ 0.127∗∗∗ 0.271∗∗∗
(0.016) (0.052) (0.019) (0.023) ( 0.105)
GDP per capita 1.070∗∗∗ 0.995∗∗∗ 1.102∗∗∗ 1.003∗∗∗ 1.408∗∗∗
first lag (0.052) (0.1592) (0.086) (0.024) (0.066)
GDP per capita -0.030 -0.005 -0.028 -0.002 -0.381∗∗∗
second lag (0.023) (0.156) (0.082) (0.011) (0.104)
GDP per capita -0.067∗∗ -0.010∗∗∗ -0.111∗∗∗ -0.020 -0.084
third lag (0.030) (0.024) (0.033) (0.013) (0.052)
Long run 3.511∗∗∗ 6.784∗∗ 2.132∗∗∗ 6.795∗∗∗ 4.774∗∗∗
effect of health (0.917) (2.179) (0.732) (2.596) (1.269)
Persistence 0.973∗∗∗ 0.980∗∗∗ 0.963∗∗∗ 0.981∗∗∗ 0.943∗∗∗
in GDP per capita (0.005) (0.009) (0.009) (0.006) (0.009)
Observations 7,330 1,377 2,653 1,608 1,692
No. of country 182 35 63 35 49
Panel B: GMM estimates
Health effects 0.146∗∗∗ 0.133∗∗ 0.116∗∗∗ 0.141∗∗∗ 0.272 ∗∗∗
(0.024) (0.052) (0.024) (0.026) (0.103)
GDP per capita 1.034∗∗∗ 0.995∗∗∗ 1.072∗∗∗ 1.000∗∗∗ 1.408∗∗∗
first lag (0.048) (0.159) (0.087) (0.023) (0.064)
GDP per capita -0.021 -0.005 -0.026 -0.002 -0.380∗∗∗
second lag (0.022) (0.156) (0.080) (0.010) (0.103)
GDP per capita -0.050∗∗ -0.010∗∗∗ -0.094∗∗∗ -0.019 -0.084∗
third lag (0.026) (0.024) (0.030) (0.013) (0.051)
Long run 3.955∗∗∗ 6.536∗∗∗ 3.004∗∗∗ 6.686∗∗∗ 4.774∗∗∗
effect of health (0.679) (2.086) (0.476) (2.344) (1.251)
Persistence 0.963∗∗∗ 0.980∗∗∗ 0.952∗∗∗ 0.979∗∗∗ 0.943∗∗∗
in GDP per capita (0.007) (0.009) (0.009) (0.007) (0.009)
AR2 test (p-value) [0.164] [0.178] [0.064] [0.011] [0.378]
Observations 7,133 1,339 2,586 1,565 1,643
No. of country 179 34 63 33 49
Note: The dependent variable is log of GDP per capita and independent variable is log of life
expectancy at birth. Column 1 covers the whole world which is produced from the Table 2 to
compare with different subsamples. Columns 2-5 indicate estimates considering countries of Asia
region (Southeast Asia, Asia-Pacific and Western Asia), Africa region (Sub-Sahara Africa and Arab),
America region (North, Latin America and Caribbean countries), and Europe region (European and
Central Asia) respectively. We use our preferred lags in this table: three lags are used as a preferred
lags in our analysis. Robust standard errors for heteroskedasticity at the country level and serial
correlation are reported in parentheses. All specifications include country and year fixed effects.
∗p <0.10, ∗∗p <0.05, ∗∗∗p <0.01.
Moreover, we investigate the robustness of GMM estimates using alternative
GMM estimator. While employing Arellano-Bond estimator we may have finite
sample biased estimates due to instrumental proliferation. To overcome this
problem, we employ alternative GMM estimator using truncated lags to 25.
This reduces instruments largely, however our results remain similar to preferred
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estimates of GMM (column 3, Appendix A, Table A.1).
Finally, our analysis deals with the presence of outliers reported in Appendix
A, Table A.2 (columns 2-3). Excluding observations more and less than
three standard deviations from mean, we estimate our preferred specification
(column 2). Secondly, we account for outliers using Cook’s distance where we
exclude observations above a common rule-of-thumb threshold (four divided by
the number of observations) (column 3). In both cases, results are very similar
to our baseline findings which substantiate that our results are not influenced
by outliers.
Overall, we use dynamic fixed effects estimators as well as Arellano-Bond
GMM estimators: Both estimators provides very close results. Even though
there have not been accounted for external instruments-which take into account
the exogenous sources of variation in health-we consider robustness of our
preferred estimates considering several time-varying controls both in dynamic
within and GMM estimators. More importantly, panel data can sometimes
capture the exogenous variation in institutions or policies through repeated
observations of the same individual over long time period (Arellano, 2003). In
addition, the panel data estimators we consider in this empirical research have
asymptomatic properties: They can have consistent estimates as time period
goes to infinity. Furthermore, the correlations of error terms-where time-varying
factors contain-become less and less and eventually disappear as time period
extends to infinity: This implies that estimates are consistent. Nonetheless, we
intend to extend this discussion further to explore the asymptotic properties
of dynamic estimators including external instruments in dynamic fixed effects
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model in future.
4 Mechanisms and Test
As noted earlier, the existing literature has acknowledged the importance of
mechanisms through which health affects income (e.g., Barro, 1996; Aghion
et al., 2010; Zhang and Zhang, 2005). We investigate the channels and find
that life expectancy has a significantly positive relationship with saving and
negative relationship with fertility in the long-run.
To explore these channels or intermediate factors, we employ the following
dynamic panel model:
cit = βhit +
q∑
l=1
θlcit−l + αi + γt + uit (2)
Where, cit is one of possible channels that has effect on GDP. In this aspect, β
indicates the impact of health on each channel. θl indicates coefficient of l
th
lagged dependent variables of each channel which captures persistence in each
channel. All other terms are the same as equation (1).
The channels we take into account include saving and fertility. Table 6
presents that life expectancy has a significantly positive effect on saving (col-
umn 1). However, it has a significantly negative effect on fertility (column 2).
19
Table 6: The effect of life expectancy on channels
(1) (2) (3)
Health 1.562∗∗∗ -0.033∗∗∗ 0.013
(0.360) (0.005) (0.028)
Long run effect 10.391∗∗∗ -1.572∗∗∗ 0.191
of health (1.438) (0.205) (0.397)
Persistence 0.850∗∗∗ 0.979∗∗∗ 0.930∗∗∗
in outcome (0.019) (0.002) (0.007)
Saving 0.016∗∗∗
(0.002)
Fertility -0.024∗∗∗
(0.006)
Observations 4,274 9,497 4,069
No. of country 169 182 137
Note: Dependent variables are channels while independent vari-
able is log of life expectancy in columns 1-2 while column 3
indicates the test of mechanisms. Columns 1-2 report impacts
of life expectancy on saving, and fertility respectively. Life
expectancy, saving and fertility are in log form. Each channel
is considered with 3 lags. In column 3, dependent variable is
log of GDP per capita and independent variable is log of life
expectancy and indicates estimates in the presence of channels
such as saving, and fertility. Robust standard errors for het-
eroskedasticity at the country level and serial correlation are
reported in parentheses. All specifications include country and
year fixed effects.
∗p <0.10, ∗∗p <0.05, ∗∗∗p <0.01.
The presence of channels with life expectancy on the regression 1 leads to no
effect of life expectancy on income suggests that our channels work on income.
Column 3 of Table 6 demonstrates the test of mechanisms after considering
all channels in equation 1. Results indicate that the relationship between
life expectancy and GDP per capita vanishes when considering all channels
together. Our channels such as saving is positive and significantly correlated
with income while fertility is negatively correlated with income. Thus, this
test proves empirically that our channels are potentials through which life
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expectancy acts on income.
5 Conclusions
In this paper, we focus on the direct causal relationship between GDP per
capita and life expectancy at birth using dynamic panel data models. Our
paper employs the dynamic fixed effects estimator using a big longitudinal
annual dataset over 1960-2015. This panel dataset covers the time regimes over
2000-2015 at which world leaders setup MDGs and health has substantially
improved by reducing child mortality rates globally. Capturing the persistence
in GDP per capita, we can consistently estimate parameter and models allow
us to find the long-run effects of life expectancy at birth.
Our baseline results show that life expectancy has a significantly posi-
tive relationship with GDP per capita using the dynamic within estimator.
When using lags as internal instruments in GMM estimator, the effects of life
expectancy are similar to our preferred within estimates. Our analysis also
explores mechanisms via which life expectancy acts on GDP per capita such
as saving and fertility. The test of mechanisms provides evidence that life
expectancy increases GDP per capita by decreasing fertility and increasing
saving.
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Appendix A: Tables
Table A.1: The effect of life expectancy on GDP per capita with alternative GMM
estimator
(1) (2) (3)
Health outcome 0.095∗∗∗ 0.146∗∗∗ 0.202∗∗∗
(0.016) (0.024) (0.036)
Long-run effect 3.511∗∗∗ 3.955∗∗∗ 3.309∗∗∗
of health (0.917) (0.679) (0.577)
Persistence in 0.973∗∗∗ 0.963∗∗∗ 0.939∗∗∗
GDP per capita (0.005) (0.007) (0.012)
AR2 test (p-value) [0.164] [0.443]
No. of instruments 3,006 2,198
Observations 7,330 7,133 3,376
No. of country 182 179 147
Note: Dependent variable is log of GDP per capita while in-
dependent variable is log of total life expectancy. Column 1
presents preferred estimates in our baseline model. Columns 2
indicates preferred estimates from GMM estimator while col-
umn 3 denotes estimates using truncated lags to 25. All models
include country fixed and year fixed effects. Robust standard
errors for heteroskedasticity at the country level and serial cor-
relation are reported in parentheses.
∗p <0.10, ∗∗p <0.05, ∗∗∗p <0.01.
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Table A.2: The effect of life expectancy on GDP per capita
(1) (2) (3)
Health 0.095∗∗∗ 0.090∗∗∗ 0.117∗∗∗
(0.016) (0.015) (0.017)
GDP per capita 1.070∗∗∗ 1.173∗∗∗ 1.153∗∗∗
first lag (0.052) (0.063) (0.068)
GDP per capita -0.030 -0.099 -0.086
second lag (0.023) (0.073) (0.076)
GDP per capita -0.067∗ -0.104∗∗∗ -0.1002∗∗∗
third lag (0.030) (0.024) (0.023)
Long-run effect 3.511∗∗∗ 3.059∗∗∗ 3.559∗∗∗
of health (0.917) (0.676) (0.557)
Persistence 0.973∗∗∗ 0.971∗∗∗ 0.967∗∗∗
in GDP (0.005) (0.004) (0.005)
Observations 7,330 7,259 6,958
No. of country 182 178 178
Note: Dependent variable is log of GDP per capita while in-
dependent variable is log of total life expectancy. Column 1
presents preferred estimates in our baseline model. Columns 2
and 3 indicates estimates using our preferred specification.
Column 2 denotes the estimates when excluding observations
which have more or less standard deviation from mean. Col-
umn 3 shows Cook’s distance when observations are above a
common rule-of-thumb threshold. All models include country
fixed and year fixed effects. Robust standard errors for het-
eroskedasticity at the country level and serial correlation are
reported in parentheses.
∗p <0.10, ∗∗p <0.05, ∗∗∗p <0.01.
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Appendix B: Figures
Figure.B1: The distribution of log (GDP per capita) with box diagram.
Note: logypccc denotes the log of GDP per capita (constant US dollar).
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Figure.B2: The distribution of log (life expectancy at birth) with box diagram.
Note: loglet denotes the log of life expectancy at birth.
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